In the final episode of Kicking the Nicotine Habit, It's a Brain Thing. The MedEvidence! doctors roll out the clinical trials on Cytisinicline, an approved therapy in Central and Eastern West Europe for the past 20 years. 

Dr. Michael Koren, MedEvidence! Podcast Host, Lead Investigator on 2,000+ clinical trials, and practicing Cardiovascular physician with co-host Michelle McCormick talks with Dr. Mitchell Rothstein a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville Florida area.  Dr. Rothstein transitioned into Clinical Research as the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research six years ago.

Inside this episode:

• Cytisinicline
• Alpha4beta2 Nicotine Receptor
• Clinical Trials to help quit smoking

Listen to the entire series:

• Part 1 Kicking the Nicotine Habit, It's a Brain Thing
• Part 2 Five Strategies to Stop Smoking
• Part 3 Nicotine Replacement Therapies to Help Stop Smoking
• Part 4 Advances in Smoking Cessation

Links to more information:

• A naturally-derived alternative treatment to quit smoking

• Ongoing Research of Cytisinicline for Addiction 

• More about Clinical Trial Participation

  • Am I eligible to participate in this study?
  • Why Should I participate in this study?
  • What happens if I volunteer to participate in this study?

• Participate in Clinical Research 

Original Air Date: April 13, 2022

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!